Insider Transactions in Q1 2023 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2023
|
Michael Raab |
SELL
Open market or private sale
|
Direct |
4,408
-6.84%
|
$48,488
$11.33 P/Share
|
|
Mar 17
2023
|
Michael Raab |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.89%
|
$45,000
$3.32 P/Share
|
|
Mar 15
2023
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,375
-1.6%
|
$147,125
$11.43 P/Share
|
|
Mar 15
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.61%
|
$66,484
$11.34 P/Share
|
|
Mar 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.3%
|
$78,572
$13.49 P/Share
|
|
Mar 01
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-1.17%
|
$260,000
$13.4 P/Share
|
|
Mar 01
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.35%
|
$23,400
$2.45 P/Share
|
|
Feb 15
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.6%
|
$72,528
$12.94 P/Share
|
|
Feb 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
147,316
-12.79%
|
$1,915,108
$13.11 P/Share
|
|
Feb 01
2023
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
139,929
+5.88%
|
$699,645
$5.62 P/Share
|
|
Feb 01
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-2.31%
|
$240,000
$12.98 P/Share
|
|
Feb 01
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.33%
|
$23,400
$2.45 P/Share
|
|
Jan 24
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
31,839
-8.74%
|
$413,907
$13.32 P/Share
|
|
Jan 18
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,923
-1.71%
|
$89,999
$13.0 P/Share
|
|
Jan 18
2023
|
David Michael Clark Chief People Officer |
SELL
Open market or private sale
|
Direct |
7,382
-2.97%
|
$95,966
$13.5 P/Share
|
|
Jan 17
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.22%
|
$60,000
$12.49 P/Share
|
|
Jan 13
2023
|
Margaret G Mcglynn |
SELL
Open market or private sale
|
Direct |
15,000
-22.83%
|
$195,000
$13.03 P/Share
|
|
Jan 13
2023
|
Margaret G Mcglynn |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.59%
|
$45,000
$3.32 P/Share
|
|
Jan 11
2023
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,147
-5.55%
|
$601,764
$12.02 P/Share
|
|
Jan 11
2023
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
98,040
+9.79%
|
-
|
|
Jan 11
2023
|
Jeff Castelli Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,325
-5.97%
|
$291,900
$12.02 P/Share
|
|
Jan 11
2023
|
Jeff Castelli Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,024
+12.09%
|
-
|
|
Jan 11
2023
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,738
-7.01%
|
$224,856
$12.02 P/Share
|
|
Jan 11
2023
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,621
+15.13%
|
-
|
|
Jan 11
2023
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
83,261
-7.6%
|
$999,132
$12.02 P/Share
|
|
Jan 11
2023
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
210,088
+16.09%
|
-
|
|
Jan 11
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29,565
-6.72%
|
$354,780
$12.02 P/Share
|
|
Jan 11
2023
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,824
+11.79%
|
-
|
|
Jan 11
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,185
-6.23%
|
$290,220
$12.02 P/Share
|
|
Jan 11
2023
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,024
+12.61%
|
-
|
|
Jan 09
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
11,700
-1.43%
|
$128,700
$11.43 P/Share
|
|
Jan 09
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.41%
|
$23,400
$2.45 P/Share
|
|
Jan 09
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
85,102
-8.77%
|
$936,122
$11.43 P/Share
|
|
Jan 06
2023
|
David Michael Clark Chief People Officer |
SELL
Open market or private sale
|
Direct |
21,507
-8.92%
|
$236,577
$11.87 P/Share
|
|
Jan 04
2023
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,692
-1.1%
|
$32,304
$12.03 P/Share
|
|
Jan 04
2023
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
10,659
-1.09%
|
$127,908
$12.03 P/Share
|
|
Jan 04
2023
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,094
-0.87%
|
$85,128
$12.03 P/Share
|
|
Jan 04
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,884
-1.01%
|
$46,608
$12.03 P/Share
|
|
Jan 04
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,575
-1.06%
|
$42,900
$12.03 P/Share
|
|
Jan 04
2023
|
Jeff Castelli Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,127
-0.88%
|
$37,524
$12.03 P/Share
|
|
Jan 03
2023
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,810
-2.33%
|
$63,910
$11.93 P/Share
|
|
Jan 03
2023
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,372
+19.22%
|
-
|
|
Jan 03
2023
|
David Michael Clark Chief People Officer |
SELL
Open market or private sale
|
Direct |
8,493
-4.27%
|
$101,916
$12.03 P/Share
|
|
Jan 03
2023
|
Jeff Castelli Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,411
-1.78%
|
$70,521
$11.93 P/Share
|
|
Jan 03
2023
|
Jeff Castelli Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,681
+16.37%
|
-
|
|
Jan 03
2023
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,048
-2.29%
|
$209,528
$11.93 P/Share
|
|
Jan 03
2023
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
169,635
+16.94%
|
-
|
|
Jan 03
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,575
-2.18%
|
$94,325
$11.93 P/Share
|
|
Jan 03
2023
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,508
+15.74%
|
-
|
|
Jan 03
2023
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
233,248
+19.21%
|
-
|